Internal Medicine Residency News, Sept. 8, 2020
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Sept. 8, 2020.
Advancing the innovators of the Department of Medicine
The inaugural Department of Medicine Innovators Academy was an eight-week course customized for early career faculty interested in advancing new ideas, interventions, and technologies.
Faculty promotions approved by Board of Trustees
Congratulations to the following faculty members for their recent promotion in the Department of Medicine.
Goldstein promoted to Associate Professor
Congratulations to Karen Goldstein, MD, who is receiving a distinguished academic promotion in the division of General Internal Medicine!
Opportunities in diversity and inclusion
The Department of Medicine is actively working to embed diversity, equity, and inclusion (DEI) into everything we do.
There are many existing and soon-to-launch activities in the Department of Medicine for faculty and trainees to participate in.
"My hope is that you will find an opportunity to help make our department a place in which each person feels included, respected, and valued," says Dr. Svetkey.
Internal Medicine Residency News, Aug. 31, 2020
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Aug. 31, 2020.
Funding opp: Translating Duke Health Cardiovascular Disease Initiative – COVID-19
Duke Health has announced a request for innovative pilot project proposals for high risk/high impact research in the area of the heart disease and COVID-19. Applications are due Sept. 21, 2020.
Register today: School of Medicine New Faculty Orientation seminar series
Register today for School of Medicine's New Faculty Orientation series, which will be offered as a series of seminars beginning in September.
At the Intersection of Sickle Cell Disease and Geriatrics with Charity Oyedeji
Charity Oyedeji, MD, a senior fellow in the Division of Hematology, is exploring the intersection of geriatrics and sickle cell disease. It’s a new field because in the past, most people with the disease did not reach adulthood.